Table 2.

Univariate and multivariate Cox analysis of prognostic factors in DLBCL (OS).

Prognostic factors	Adverse factors	One-way ANOVA		Multivariate Cox analysis
		eta	p-value	HR (95% CI)	p-value
Sexual distinction	Male	0.076	0.555
Age	≥ 60	0.013	0.919
Position	Extranodal	0.08	0.533
Origin	Non-GCB	0.015	0.906
MYC	≥ 40%	0.038	0.768
BCL-2	≥ 50%	0.193	0.129	1.17 (0.535–2.555)	0.694
BCL-6	≥ 30%	0.154	0.227
P53	≥ 50%	0.028	0.826
FMYC	+	0.058	0.649
FBCL6	+	0.139	0.279
Ki-67	≥ 80%	0.041	0.750
LDH(IU/L)	≥ 250	0.358	0.004	2.542 (1.219–5.303)	0.013
Seralbumin (g/L)	≥ 40	0.028	0.827
AST	≥ 50	0.064	0.616
β2-MG	≥ 3	0.101	0.431
Stage	III, IV	0.234	0.065	1.688 (0.662–4.307)	0.273
B symptom	Yes	0.143	0.263
Extranodal number	≥ 2	0.195	0.126	0.713 (0.337–1.507)	0.376
Bulky	Yes	0.032	0.806
ECOG	≥ 2	0.211	0.097	0.692 (0.344–1.393)	0.302
R 2	No	0.068	0.596
POD12	Yes	0.334	0.008	0.274 (0.123–0.606)	0.001
NLR	≥ 1.73	0.185	0.148	1.185 (0.391–3.585)	0.764
PLR	≥ 306.494	0.051	0.690
SII	≥ 304.2	0.164	0.198	0.525 (0.182–1.518)	0.234
LMR	≥4.867	0.043	0.736